PROGESTERONE MICRONIZED

Progesterone micronized enhances bioavailability for hormone therapy in menopause, fertility treatment, and luteal support. Side effects include drowsiness, breast tenderness, mood changes, and bloating. Only GMP materials will be supplied, logistics all according to GDP.

SKU: 49b541f3961c Category: Tag:

Product Description


Mechanism of Action

PROGESTERONE MICRONIZED demonstrates a highcomplexity biochemical interaction profile characterised by multilayer signalling integration, modular enzymatic pathway penetration, mitochondrial network modulation, ionflux recalibration, redoxstate equilibrium restructuring and transcriptionfactor axis reprogramming. Its molecular geometry enables conformational docking to catalytic pockets, allosteric domains, transmembrane receptor helices and cytoskeletal scaffolds, creating broad regulatory influence across metabolic, structural and genomic systems.

At the signalling level, PROGESTERONE MICRONIZED may modulate phosphorylation gradients, kinome cascade propagation (including MAPK, JNK, ERK, PI3KAKT, and AMPK axes), Gprotein subunit turnover, calcium wave propagation, secondary messenger amplification and stressadaptation thresholds. Mitochondrially, the compound can alter electrontransportchain efficiency, ATPADP cycling, mitochondrial ROS leakage, membrane potential polarity and respiratorycomplex activation ratios.

Advanced Research Value

PROGESTERONE MICRONIZED is particularly suited for:

  • Crosspathway interference mapping and kinome interaction grids
  • Ultrahigh resolution receptorligand docking and conformational prediction
  • Organellestress modelling (ER stress, mitochondrial folding stress, autophagic flux modulation)
  • Networklevel transcriptome rewiring using multiomics clustering
  • Precision cytoskeletalmechanics analysis including actin polymerisation and tubulin turnover
  • Apoptotic vs. survivalpathway bias quantification
  • Advanced SAR, QSAR and machinelearning molecularperformance modelling

Risks, Toxicodynamics & Cellular Hazard Spectrum

At elevated exposure levels, PROGESTERONE MICRONIZED may induce:

  • ROS surge and oxidative collapse
  • Mitochondrial hyperfragmentation or respiratorycomplex shutdown
  • Severe ionchannel destabilisation
  • Cytoskeletal disassembly and membrane-integrity breach
  • Aberrant transcriptionfactor activation, inflammatory bursts (NF-κB, STAT, IRF pathways)
  • Highgrade apoptosis, necroptosis or ferroptosis initiation
  • Epigenetic instability affecting methylation/acetylation balance

Only GMP materials will be supplied, logistics all according to GDP.

Datasheet


Molecular Formula

C21H30O2

Molecular Weight

314.46 g/mol

CAS Number

57-83-0

Storage Condition

Store at 2-8°C

Solubility

Soluble in water

Purity

Purity information is available upon request (COA).

Synonym

MFCD00010483; 17-Hydroxy-6-methylpregn-4-ene-3,20-dione 17-acetate; SCHEMBL14262777; BDBM86680; PSGAAPLEWMOORI-UHFFFAOYSA-N

IUPAC/Chemical Name

(8S,9S,10R,13S,14S,17S)-17-acetyloxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one

InChl Key

Unavailable

InChl Code

Unavailable

References

PubChem; ChemBL; FDA;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download